Global Digital PCR (dPCR) Market 2015-2019 - Advances in Technology / Availability of Alternate Technologies / Adoption of dPCR

Dublin, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/4dhxmc/global_digital) has announced the addition of the "Global Digital PCR (dPCR) Market 2015-2019" report to their offering.

The Global dPCR market to grow at a CAGR of 26.45 percent over the period 2014-2019.

The report, the Global dPCR Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region, and the EMEA region; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Advanced dPCR (Digital PCR) technology provides higher accuracy and reproducibility than traditional PCR technology in the amplification and analysis of nucleic acids. The dPCR technology is an innovative PCR that allows amplification and directs quantification of nucleic acids such as DNA, RNA, cDNA, and methylated DNA with high precision. The dPCR technology is not dependent on the number of amplification cycles to quantify the initial sample amount and provides absolute quantification of nucleic acids. dPCR can analyze a small amount of sample and provide higher accuracy, precision, and efficiency than the conventional PCR technology.

According to the report, one of the major drivers of the market is advances in dPCR technology. dPCR technologies and products have improved because of automation, accuracy, sensitivity, and ease of handling. In addition, advanced dPCR products provide greater efficiency and productivity in research and drug discovery and help reduce the time taken for the development of new drugs.

Further, the report states that availability of alternative technologies is a major challenge that the market faces. Availability of other sequencing technologies such as other PCR techniques and NGS poses a serious threat to the adoption of dPCR technology.

The dPCR technologies have a broad range of applications in various fields including:

• Drug discovery and development
• Clinical diagnostics
• Research
• Others
  

Key Vendors

• Bio-Rad Laboratories
• Fluidigm
• RainDance Technologies
• Thermo Fisher Scientific

Other Prominent Vendors

• Abbott Laboratories
• Affymetrix
• Analytik Jena
• ArcticZymes
• Becton Dickinson
• Bibby Scientific
• bioMerieux
• Biosearch Technologies
• BIOTECON Diagnostics
• Eppendorf
• Exiqon
• Formulatrix
• Illumina
• Integrated DNA Technologies
• Promega
• Sigma-Aldrich
• Stilla Technologies
  

For more information visit http://www.researchandmarkets.com/research/4dhxmc/global_digital

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716